The Aporia
On September 17, 2026, the Pentagon announced it was resuming a controversial program of mandatory testosterone testing for US service members aged 30 and older. This decision follows Defense Secretary Pete Hegseth's initial announcement in July to screen for "testosterone deficiency," aimed at improving military readiness but facing criticism from medical experts who argue that such screenings are unnecessary and potentially harmful. The Pentagon had paused the program earlier in September to make updates, but now it is proceeding despite concerns about its efficacy and safety.
The new guidance specifies that only male service members will undergo mandatory testing; female service members will be screened through questionnaires instead, if at all. Medical experts have warned that inappropriate use of testosterone could lead to serious health complications such as infertility for service members who do not need it medically. This policy shift reflects broader trends in public interest driven by men’s health influencers and podcasters promoting the benefits of hormone therapy without sufficient scientific evidence supporting those claims.